HIV type 1 V3 serotyping of Tanzanian samples:: Probable reasons for mismatching with genetic subtyping

被引:37
作者
Hoelscher, M
Hanker, S
Barin, F
Cheingsong-Popov, R
Dietrich, U
Jordan-Harder, B
Olaleye, D
Nägele, E
Markuzzi, A
Mwakagile, D
Minja, F
Weber, J
Gürtler, L
Von Sonnenburg, F
机构
[1] Univ Munich, Dept Trop Med & Infect Dis, D-80802 Munich, Germany
[2] Univ Tours, Dept Microbiol & Mol, F-37044 Tours, France
[3] Imperial Coll, Sch Med St Marys, Dept Genitourinary Med, London W2 1PG, England
[4] Georg Speyer Haus, D-60596 Frankfurt, Germany
[5] Univ Dar Es Salaam, Muhimbili Med Ctr, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania
[6] Minist Hlth Tanzania, Reg Med Off, Mbeya, Tanzania
[7] Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany
关键词
D O I
10.1089/aid.1998.14.139
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1 V3 serotyping is used to classify immunodeficiency viruses on the basis of antibody binding to V3 peptides derived from env genetic subtypes. Although it shows a reasonable overlap, it has been reported to be distinct from viral genetic subtypes. The aim of this study is to determine the feasibility of HIV-1 serotyping to predict genetic subtypes in an East African setting, where multiple HIV-1 subtypes have coexisted for many years. HIV-1 genetic subtypes of 86 AIDS patients in Mbeya Town, southwest Tanzania, mere determined, using env nucleic acid sequencing as the basis for comparison. Those data were compared with V3 serotyping results obtained by four different methodologies. Four HIV-1 genetic subtypes were identified, including A (25, 29%), C (47, 55%), D (13, 15%), and G (1, 1%). The sensitivity and specificity of those serotyping assays varied considerably: sensitivity for genetic subtype A (40-48%), C (52-96%), and D (9-31%); and specificity for genetic subtype A (77-95%), C (46-63%), and D (97-100%). We further tried to identify reasons for the discrepancies between serotyping results and genetic subtypes. By means of logistic regression analysis three amino acid residues within the V3 loop (positions 12, 13, and 19; V, H, and A for serotype A, I, R, and T for serotype C) were found to be most important for antibody binding; a deviation from the subtype-specific amino acids was highly related to mismatched results. In addition, we have shown that phenetic analysis of V3 amino acid sequence data could be used to predict the majority of V3 serotypes (93-94%). Our data demonstrated that for the majority of specimens HIV-1 V3 serotyping results closely match the subtype of the analyzed sample as revealed by the V3 loop amino acid sequence. However, our data demonstrate that HIV-1 serotyping is not sufficiently accurate to predict genetic subtypes in Tanzania, where subtypes A, C, D, and G are circulating. This was due to highly similar amino acid sequences throughout the prevalent genetic subtypes, which caused the inability of HIV-1 V3 serotyping to differentiate subtype A from C as well as D from C. Instead, the serotyping results reflect the frequency distribution of V3 serotypes. To investigate HIV-1 genetic subtypes in population-based studies in this African setting additional or modified algorithms are needed.
引用
收藏
页码:139 / 149
页数:11
相关论文
共 28 条
[1]   Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: An approach for HIV type 1 serological subtyping [J].
Barin, F ;
Lahbabi, Y ;
Buzelay, L ;
Lejeune, B ;
BaillouBeaufils, A ;
Denis, F ;
Mathiot, C ;
MBoup, S ;
Vithayasai, V ;
Dietrich, U ;
Goudeau, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (13) :1279-1289
[2]   Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: A new surveillance tool for molecular epidemiology [J].
Cassol, S ;
Weniger, BG ;
Babu, PG ;
Salminen, MO ;
Zheng, XW ;
Htoon, MT ;
Delaney, A ;
OShaughnessy, M ;
Ou, CY .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (15) :1435-1441
[3]   SEROTYPING HIV TYPE-1 BY ANTIBODY-BINDING TO THE V3 LOOP - RELATIONSHIP TO VIRAL GENOTYPE [J].
CHEINGSONGPOPOV, R ;
LISTER, S ;
CALLOW, D ;
KALEEBU, P ;
BEDDOWS, S ;
WEBER, J ;
OSMANOV, S ;
BELSEY, EM ;
HEYWARD, W ;
ESPARZA, J ;
GALVAOCASTRO, B ;
VANDEPERRE, P ;
KARITA, E ;
WASI, C ;
SEMPALA, S ;
TUGUME, B ;
BIRYAHWAHO, B ;
RUBSAMENWAIGMANN, H ;
VONBRIESEN, H ;
ESSER, R ;
GREZ, M ;
HOLMES, H ;
NEWBERRY, A ;
RANJBAR, S ;
TOMLINSON, P ;
BRADAC, J ;
MCCUTCHAN, F ;
LOUWAGIE, J ;
HEGERICH, P ;
LOPEZGALINDEZ, C ;
OLIVARES, I ;
DOPAZO, J ;
MULLINS, JI ;
DELWART, EL ;
BACHMANN, HM ;
GOUDSMIT, J ;
DEWOLF, F ;
HAHN, BH ;
GAO, F ;
YUE, L ;
SARAGOSTI, S ;
SCHOCHETMAN, G ;
KALISH, M ;
LUO, CC ;
GEORGE, R ;
PAU, CP ;
NARA, P ;
FENYO, EM ;
ALBERT, J ;
MYERS, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) :1379-1386
[4]  
CHEINGSONGPOPOV R, 1997, UNPUB AIDS RES HUM R
[5]  
Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45
[6]   GENETIC-RELATIONSHIPS DETERMINED BY A DNA HETERODUPLEX MOBILITY ASSAY - ANALYSIS OF HIV-1 ENV GENES [J].
DELWART, EL ;
SHPAER, EG ;
LOUWAGIE, J ;
MCCUTCHAN, FE ;
GREZ, M ;
RUBSAMENWAIGMANN, H ;
MULLINS, JI .
SCIENCE, 1993, 262 (5137) :1257-1261
[7]  
DELWART EL, 1995, PCR METH APPL, V4, P202
[8]  
*EXP GROUP JOINT U, 1997, AIDS, V11, pS1
[9]   Molecular epidemiology of HIV in Israel [J].
Gehring, S ;
Maayan, S ;
Ruppach, H ;
Balfe, P ;
Juraszczyk, J ;
Yust, I ;
Vardinon, N ;
Rimlawi, A ;
Polak, S ;
Bentwich, Z ;
RubsamenWaigmann, H ;
Dietrich, U .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 15 (04) :296-303
[10]   Basic methods for sensitivity analysis of biases [J].
Greenland, S .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1996, 25 (06) :1107-1116